Need help? Email us and our team of experts will reply [email protected]

 
 
CJC-1295 (NoDAC) + Ipamorelin
CJC-1295 (NoDAC) + Ipamorelin - Image 2

CJC-1295 (NoDAC) + Ipamorelin

Certificate of Analysis

Third-party tested for 99% purity, ID, quantity.

Certificate of Analysis

Third-party tested for endotoxins

26152001
26152001
26152001
26152001
5/5 – 10 mg

Two-component synthetic peptide blend. Reference material for in vitro laboratory research use only.

Component Details
Component Fill CAS MW
CJC-1295 (no DAC) 5 mg 863288-34-0 3367.90
Ipamorelin 5 mg 170851-70-4 711.85
CJC-1295 sequence (3-letter) H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Ipamorelin sequence (3-letter) H-Aib-His-D-2-Nal-D-Phe-Lys-NH2
Net content 10 mg per vial (gross fill; actual content per lot COA)
Form Lyophilized powder
Storage ?20 °C, desiccated, sealed under inert atmosphere, protected from light
Note The CJC-1295 component is the no-DAC form. CJC-1295 with DAC is a different molecule (CAS 446262-90-4, MW 3647.25); the two differ by 279 Da on the COA.
Testing Identity and purity verified by third-party HPLC analysis; a lot-specific Certificate of Analysis is provided with each order.

Research Use Only. Not a drug, supplement, or food. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.

CJC-1295 (NoDAC) + Ipamorelin Structure

Chemical Structure Diagram

CAS: 863288-34-0
Molecular Formula: C???H???N??O??
Molecular Weight: 3367.9 g/mol
PubChem ID: 91976842
--------------------------
CAS: 170851-70-4
Molecular Formula: C???H???N??O??
Molecular Weight: 3367.9 g/mol
PubChem ID: 91976842

Research Findings

CJC-1295 and Ipamorelin have been examined in endocrine, signaling, experimental, and systemic models, with research exploring their influence on somatotroph axis pathways, downstream cascades, pathway activity, and molecular viability. Studies highlight their role in signaling kinetics, remodeling processes, and systemic resilience in preclinical settings.

Key Areas of Research:

  • Endocrine: Somatotroph axis, signaling, cascades

  • Signaling: Lipid pathways, dynamics, markers

  • Molecular: Proliferation, remodeling, viability

  • Systemic: Vascular, resilience, pathway activity

Together, these findings suggest broad experimental potential for CJC-1295 and Ipamorelin across multiple biological pathways. By modulating endocrine signaling, influencing downstream pathway activity, and supporting molecular and systemic resilience, this combination provides a versatile platform for research into remodeling, pathway dynamics, and experimental modeling in laboratory settings.

Teichman S.L. et al., Journal of Clinical Endocrinology & Metabolism, 2006

References

Teichman S.L. et al. (2006). Prolonged stimulation of GH and IGF-1 secretion by CJC-1295 in healthy adults. J Clin Endocrinol Metab, 91(3):799-805. 

Lapierre S.S. et al. (2006). Sustained GH and IGF-1 responses to CJC-1295 in GHRH knockout mice. Am J Physiol Endocrinol Metab, 291(2):E282-E287.

Svensson J. et al. (1998). Ipamorelin selectively stimulates GH release without affecting cortisol or prolactin. J Clin Endocrinol Metab, 83(9):3094-3101.

Culler M.D. et al. (2002). Pharmacological characterization of ipamorelin, a novel GHRP with GH selectivity. J Endocrinol, 174(2):R1-R6.

Our Process

View Products

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our
U.S. facility.

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our
U.S. facility.

Email us, our dedicated team is here to help

Reach out and get a response within minutes.

Email Us

Frequently Asked Questions

Everything you need to know about our products and processes.

View Products

Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.

 
Peptides are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.
 
 
In lyophilized powder form, peptides stay stable for up to 2 years. After reconstitution, it should be refrigerated and is generally stable for up to 2 months.
 
 
Products from us do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
 
 
Lyophilized peptides should be stored away from heat and light. Once reconstituted, they must be refrigerated to maintain stability and efficacy.